SOBRsafe Inc. (NASDAQ: SOBR), a pioneer in next-generation alcohol monitoring solutions, has achieved a milestone with the European Patent Office granting European Patent No. EP4171362 for its SOBRcheck(TM) device. This patent underscores the company's innovative approach to alcohol detection, utilizing a noninvasive transdermal system that combines skin-contact verification, biometric ID scanning, and wireless data transmission to identify alcohol consumption without the need for breath, blood, or urine samples.
The significance of this patent extends beyond technological achievement; it solidifies SOBRsafe's foothold in critical markets such as workplace safety, judicial compliance, and wellness. With planned European pilot programs slated for the second half of 2025, the company is poised to introduce a new standard in alcohol monitoring that prioritizes dignity and efficiency.
For more details on SOBRsafe's breakthrough, visit https://ibn.fm/kSwer. Further information about SOBRsafe and its technology can be found at https://www.sobrsafe.com.
This development is not just a win for SOBRsafe but represents a leap forward in how alcohol consumption is monitored, offering a less intrusive yet highly effective solution that could revolutionize safety protocols across industries and legal systems worldwide.
